← Back to catalogue

Lyher

FDA UDIEUDAMED

Class II (US FDA UDI)

by Hangzhou Laihe Biotech Co., Ltd.

Identity

Trade Name
Lyher FDA UDI
Generic Name
Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinical FDA UDI
Device Name
The Urine Marijuana (THC) Test Kit is a lateral flow chromatographic immunoassay for the qualitative detection of THC-COOH in urine at the cut-off concentrations: Marijuana (THC) 50ng/ml The test provides only a preliminary analytical test result. The test is not intended to be used in monitoring the drug levels. A more specific alternate method must be used in order to confirm the test result. Gas Chromatography/Mass Spectrometry (GC/MS), Liquid Chromatography/Mass Spectrometry (LC/MS) and their tandem mass-spectrometer versions are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test results, particularly when preliminary positive results are obtained. FDA UDI
Model / Reference
DTH-102 FDA UDI
Description
The Urine Marijuana (THC) Test Kit is a lateral flow chromatographic immunoassay for the qualitative detection of THC-COOH in urine at the cut-off concentrations: Marijuana (THC) 50ng/ml The test provides only a preliminary analytical test result. The test is not intended to be used in monitoring the drug levels. A more specific alternate method must be used in order to confirm the test result. Gas Chromatography/Mass Spectrometry (GC/MS), Liquid Chromatography/Mass Spectrometry (LC/MS) and their tandem mass-spectrometer versions are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test results, particularly when preliminary positive results are obtained. FDA UDI

Identifiers

Primary DI / UDI-DI
06972412619696 FDA UDI
510(k) Number
K232604 FDA UDI
FDA Product Code
LDJ FDA UDI
GMDN Term
Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3870 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinical

Lyher by Hangzhou Laihe Biotech Co., Ltd. — Class II — IVDD, IVDR, FDA UDI — listed in FDA GUDID, EUDAMED — regulatory data on deviCERTS

Similar devices

Also classified as Cannabinoid/cannabinoid metabolite IVD, kit, rapid ICT, clinical.

Cleared under the same submission

K232604 also covers:

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Unknown

IVDD

European Union Unknown

IVDR

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (2)

  • FDA UDI 86a2f19c-3424-42eb-85bb-f7c398b71309 34 fields · synced Jun 20, 2026
  • EUDAMED 1 fields · synced Jun 2, 2026